Host receptors – no specific therapeutic molecular target

The term Host receptors – no specific therapeutic molecular target is a nomenclature used in pharmacological databases to classify therapeutic agents whose specific molecular binding partners have not been identified (Nature Reviews Drug Discovery, 2011). This designation does not refer to a single biological entity but rather serves as a placeholder for drugs that exert their effects through broad, non-specific, or poorly understood interactions with host systems (Pharmacology & Therapeutics, 2014). Such agents often include complex biologics, certain vaccines, or legacy pharmaceuticals that were approved based on phenotypic outcomes rather than target-based drug discovery (Nature Reviews Drug Discovery, 2018). Because there is no defined protein or pathway, these therapies are often associated with polypharmacology, where multiple low-affinity interactions contribute to the clinical effect. For drug developers and analysts, this classification indicates a lack of mechanistic resolution, which can complicate the development of second-generation compounds or precise safety profiles. Consequently, this label represents a significant knowledge gap in the understanding of the drug's pharmacodynamics within the host organism.

Other names

Unspecified host receptorsNon-specific host targetsUnknown host molecular targetHost receptors (unspecified)

The mechanism of action involves non-specific modulation of host physiological processes or immune responses without binding to a single, defined molecular target.